Cargando…

Pharmacokinetics and tolerability of intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%) in 19 subjects with mild to severe renal impairment: terminal half life and peak concentration (C(max))remain unaffected

Detalles Bibliográficos
Autores principales: Jungheinrich, C, Scharpf, R, Wargenau, M, Bepperling, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333305/
http://dx.doi.org/10.1186/cc1185